TP53 gene mutations affect lung cancer treatment response, study shows

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as smoking and ethnicity. These mutations are already guiding more personalized treatments.